SPC465
Lebrikisúmab
Status:
VeittApplication date:
29.4.2024Application published:
15.5.2024Grant published:
15.12.2025
Max expiry date:
16.11.2038Medicine name:
EbglyssMedicine for children:
No
Timeline
Today
29.4.2024Application
15.5.2024Publication
15.12.2025Registration
16.11.2038Expires
Marketing license
IS authorization number:
EU/1/23/1765Date:
4.12.2023
Foreign authorization number:
EU/1/23/1765Date:
16.11.2023
Owner
Name:
F. Hoffmann-La Roche AGAddress:
Grenzacherstrasse 124, 4070 Basel CH
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113 Reykjavík
Patent
Number:
EP3528838
Deadlines
TypeDeadline until
Type: Frestur til að fara yfir drög að vottorði
Deadline until: 22.11.2025